Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank43
3Y CAGR-10.3%
5Y CAGR-5.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-10.3%/yr
vs +4.3%/yr prior
5Y CAGR
-5.3%/yr
Recent deceleration
Acceleration
-14.6pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$296.15M-15.7%
2024$351.41M-20.6%
2023$442.74M+7.8%
2022$410.60M-0.8%
2021$413.75M+6.2%
2020$389.52M-9.1%
2019$428.41M+23.6%
2018$346.64M+16.2%
2017$298.28M+8.9%
2016$273.96M-